MetaVia (MTVA) Assets (2015 - 2026)
MetaVia's (MTVA) quarterly Assets came in at $11.1 million in Q4 2025, down 31.59% YoY from $16.3 million in Q4 2024, and down 24.67% on a QoQ basis from $14.8 million in Q3 2025.
MetaVia (MTVA) Assets (2015 - 2026) Analysis & Trends
MetaVia (MTVA) has 11 years of Assets data on file, last reported at $11.1 million in Q4 2025.
- Quarterly Assets fell 31.59% year-over-year to $11.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.1 million (down 31.59% YoY) and the FY2025 annual result came in at $11.1 million, down 31.59% from the prior year.
- Assets slipped to $11.1 million in Q4 2025, from $14.8 million in the prior quarter.
- In the past five years, Assets ranged from a high of $33.5 million in Q4 2022 to a low of $7.6 million in Q3 2022.
- A 5-year average of $18.2 million and a median of $16.5 million in 2021 frame the typical range for Assets.
- Annual changes were most pronounced in 2023 — Assets surged 249.68% — and 2024, when it plunged 45.95%.
- Tracing MTVA's Assets over 5 years: stood at $16.8 million in 2021, then jumped by 99.62% to $33.5 million in 2022, then sank by 32.07% to $22.8 million in 2023, then slipped by 28.62% to $16.3 million in 2024, then tumbled by 31.59% to $11.1 million in 2025.
- The last three Assets figures came in at $11.1 million (Q4 2025), $14.8 million (Q3 2025), and $18.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | MetaVia | 8.72 Mn | -3.92 Mn | - | 13.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.27 Mn |
| Dec 31, 2025 | 11.12 Mn |
| Sep 30, 2025 | 14.77 Mn |
| Jun 30, 2025 | 18.46 Mn |
| Mar 31, 2025 | 12.13 Mn |
| Dec 31, 2024 | 16.26 Mn |
| Sep 30, 2024 | 22.15 Mn |
| Jun 30, 2024 | 28.75 Mn |
| Mar 31, 2024 | 17.02 Mn |
| Dec 31, 2023 | 22.78 Mn |
| Sep 30, 2023 | 26.43 Mn |
| Jun 30, 2023 | 29.18 Mn |
| Mar 31, 2023 | 31.49 Mn |
| Dec 31, 2022 | 33.53 Mn |
| Sep 30, 2022 | 7.56 Mn |
| Jun 30, 2022 | 10.08 Mn |
| Mar 31, 2022 | 13.46 Mn |
| Dec 31, 2021 | 16.80 Mn |
| Sep 30, 2021 | 8.08 Mn |
| Jun 30, 2021 | 10.72 Mn |